ConductScience.org, home

Paper · 40748883

Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia.

Bogale M and 14 others. PLoS One, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia. Papers, record 40748883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40748883

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia.
PubMed
Journal
PLoS One
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-28
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bogale MMihiret
2Mengstie TATiget Ayelgnhttps://orcid.org/0000-0001-6571-5080
3Tadesse EEphrem
4Dejenie TATadesse Asmamaw
5Teferi BBanchamlak
6Siferih MMelkamuhttps://orcid.org/0000-0002-6468-7708
7Takle MNMulualem Nibret
8Asefa TTseganesh
9Dessie GGashawhttps://orcid.org/0009-0000-4497-2926
10Tesfaye WWinta

1 to 10 of 15Source PubMed

See all 15 authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Polymorphism, Single NucleotideMajor topic
Receptor, Fibroblast Growth Factor, Type 2Major topic
Humans
Female
Ethiopia
Middle Aged
Case-Control Studies
Adult
Genetic Predisposition to Disease
Genotype
Alleles
Hospitals, Special
Aged

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121,795,501Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study.Cancer Epidemiol Biomarkers Prev2011https://conductscience.org/library/papers/21795501PubMed
227,966,449Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.Oncotarget2017https://conductscience.org/library/papers/27966449PubMed
321,178,401Physical activity and global genomic DNA methylation in a cancer-free population.Epigenetics2011https://conductscience.org/library/papers/21178401PubMed
435,548,083Mapping Cancer in Africa: A Comprehensive and Comparable Characterization of 34 Cancer Types Using Estimates From GLOBOCAN 2020.Front Public Health2022https://conductscience.org/library/papers/35548083PubMed
537,124,535Central obesity and its associated factors among cancer patients at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.Front Oncol2023https://conductscience.org/library/papers/37124535PubMed
617,529,967Genome-wide association study identifies novel breast cancer susceptibility loci.Nature2007https://conductscience.org/library/papers/17529967PubMed
717,529,973A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.Nat Genet2007https://conductscience.org/library/papers/17529973PubMed
819,497,954Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.Mol Endocrinol2009https://conductscience.org/library/papers/19497954PubMed
933,081,025The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives.Cancers (Basel)2020https://conductscience.org/library/papers/33081025PubMed
1021,767,389Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.Breast Cancer Res2011https://conductscience.org/library/papers/21767389PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40748883

GET https://conductscience.org/api/papers/v1/40748883/references?page=2